Browsing by Author Gil Gil, Miguel
Showing results 1 to 20 of 26
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 9-Jun-2020 | A Phase II Prospective, Randomized, Double‐Blind , Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor–Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting | Sánchez Rovira, Pedro; Lindén Hirschberg, Angelica; Gil Gil, Miguel; Bermejo de las Heras, Begoña; Nieto Magro, Concepción |
| 1-Nov-2018 | Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) | Coleman, Robert E.; Collinson, M.; Gregory, W.; Marshall, Helen; Bell, Richard; Dodwell, David; Keane, Maccon; Gil Gil, Miguel; Barrett-Lee, Peter J.; Ritchie, Diana; Bowman, A.; Liversedge, V.; Boer, R. H. de; Passos Coelho, J. L.; O'Reilly, S.; Bertelli, G.; Joffe, J.; Brown, J. E.; Wilson, C.; Tercero, J. C.; Jean Mairet, J.; Gomis, R.; Cameron, David |
| 13-Oct-2011 | Breast-cancer Adjuvant Therapy With Zoledronic Acid | Coleman, Robert E.; Marshall, Helen; Cameron, David; Dodwell, David; Burkinshaw, Roger; Keane, Maccon; Gil Gil, Miguel; Houston, Stephen J.; Grieve, Robert J.; Barrett-Lee, Peter J.; Ritchie, Diana; Pugh, Julia; Gaunt, Claire; Rea, Una; Peterson, Jennifer; Davies, Claire; Hiley, Victoria; Gregory, Walter; Bell, Richard |
| 14-Apr-2023 | CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2−Metastatic Breast Cancer | Guerrero Zotano, Ángel; Belli, Stefania; Zielinski, Christoph; Gil Gil, Miguel; Fernández Serra, Antonio; Ruíz Borrego, Manuel; Ciruelos Gil, Eva María; Pascual, Javier; Muñoz Mateu, Montserrat; Bermejo, Begoña; Margeli Vila, Mireia; Antón, Antonio; Murillo, Laura; Nissenbaum, Bella; Liu, Yuan; Herranz, Jesús; Fernández García, Daniel; Caballero, Rosalía; López Guerrero, José Antonio; Bianco, Roberto; Formisano, Luigi; Turner, Nicholas; Martín, Miguel |
| 1-May-2020 | Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial | Lindén Hirschberg, Angelica; Sánchez Rovira, Pedro; Presa Lorite, Jesús; Campos Delgado, Míriam; Gil Gil, Miguel; Lidbrink, Elisabet; Suárez Almarza, Javier; Nieto Magro, Concepción |
| 24-Aug-2016 | Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients | Molina, David; Pérez Beteta, Julián; Martínez González, Alicia; Sepúlveda, Juan M.; Peralta, Sergi; Gil Gil, Miguel; Reynes, Gaspar; Herrero, Ana; Peñas, Ramón de las; Luque, Raquel; Capellades, Jaume; Balaña, Carmen; Pérez García, Víctor M. |
| 1-Oct-2021 | Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study | Kahan, Zsuzsanna; Gil Gil, Miguel; Ruiz Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo, Begoña; Margeli, Mireia; Antón, Antonio; Casas, Maribel; Csöszi, Tibor; Murillo, Laura; Morales, Serafín; Calvo, Lourdes; Lang, Istvan; Alba, Emilio; Haba Rodriguez, Juan de la; Ramos, Manuel; Álvarez López, Isabel; Gal Yam, Einav; García Palomo, Andrés; Alvarez, Elena; González Santiago, Santiago; Rodríguez, César A.; Servitja, Sonia; Corsaro, Massimo; Rodrigálvarez, Graciela; Zielinski, Christoph; Martín, Miguel |
| 24-Jul-2020 | Immune Cell Associations with Cancer Risk | Palomero, Luis; Galvan Femenia, Ivan; Cid, Rafael de; Espín, Roderic; Barnes, Daniel R.; Blommaert, Eline; Gil Gil, Miguel; Falo, Catalina; Stradella, Agostina; Ouchi, Dan; Roso Llorach, Albert; Violan, Concepció; Peña Chilet, María; Dopazo, Joaquín; Extremera, Ana I.; Garcia Valero, Mar; Herranz, Carmen; Mateo González, Francesca; Mereu, Elisabetta; Beesley, Jonathan; Chenevix-Trench, Georgia; Roux, Cecilia; Mak, Tak; Brunet, Joan; Hakem, Razq; Gorrini, Chiara; Antoniou, Antonis C.; Lázaro García, Conxi; Pujana Genestar, M. Ángel |
| 9-Jul-2021 | Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study | Gil Gil, Miguel; Bellet, Meritxell; Bergamino Sirvén, Milana; Morales, Serafín; Barnadas, Agustí; Manso, Luís; Saura, Cristina; Fernández Ortega, Adela; Garcia Martinez, Elena; Martinez Jañez, Noelia; Melé, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Martin, X.; Ciruelos, Eva; Pernas, Sònia |
| Oct-2021 | Organización y Calidad en el ámbito hospitalario | Barba Flores, María Ángeles; Codina Jané, Carles; Corbella, Xavier; Cossio Gil, Yolima; Cuadrado Benet, Sergi; Gamell Àlvarez, Lluís; García Montoya, Encarna; Gil Gil, Miguel; Gil Martin, Marta; González-Muñoz, Esther; Mangues i Bafalluy, Ma. Antònia; Ponce i Sebastià, Jordi; Rovira Lapiedra, Vicky; Sala de Vedruna, Gemma; Salazar Macián, Ramón; Salazar Soler, Albert; Salazar Soler, Ramón; Suñé i Negre, Josep M. (Josep Maria); Tabernero Caturla, Josep; Tomás Martínez, Esther; Vidal Milla, Ángel |
| 1-May-2019 | Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication | Bellet, Meritxell; Ahmad, Faten; Villanueva, Rafael; Valdivia, Carolina; Palomino Doza, Julián; Ruiz, Ada; Gonzalez-Farre, Xavier; Adrover, Encarna; Azaro, Analía; Valls Margarit, Maria; Parra, Josep Lluís; Aguilar Company, Juan; Vidal Losada, Maria Jesús; Martin, Anastasi; Gavilá, Joaquín; Escrivá de Romaní, Santiago; Perelló, Antonia; Hernando, Cristina; Lahuerta, Ainhara; Zamora, Pilar; Reyes, Victoria; Alcalde, María; Masanas, Helena; Celiz, Pamela; Ruiz, Isabel; Gil Gil, Miguel; Seguí, Miguel Àngel; Peña, Lorena de la |
| 1-Apr-2021 | Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL | Martin, M.; Zielinski, C.; Ruiz Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo de las Heras, Begoña; Margelí Vila, Mireia; Anton, A.; Kahan, Z.; Csöszi, T.; Casas, M. I.; Murillo, L.; Morales, S.; Alba, Emilio; Gal Yam, E.; Guerrero Zotano, A.; Calvo, L.; Haba Rodríguez, J. de la; Ramos, M.; Álvarez López, Isabel; García Palomo, Andrés; Huang Bartlett, C.; Koehler, M.; Caballero, R.; Corsaro, M.; Huang, X.; García Sáenz, José Ángel; Chacón, José Ignacio; Swift, C.; Thallinger, C.; Gil Gil, Miguel |
| 27-Sep-2022 | Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial | Albanell Mestres, Joan; Pérez García, José Manuel; Gil Gil, Miguel; Curigliano, Giuseppe; Ruíz Borrego, Manuel; Comerma, Laura; Gibert, Joan; Bellet, Meritxell; Bermejo, Begoña; Calvo, Lourdes; Haba, Juan de la; Espinosa, Enrique; Minisini, Alessandro Marco; Quiroga Garcia, Vanesa; Santaballa Bertran, Ana; Mina, Leonardo; Bellosillo Paricio, Beatriz; Rojo, Federico; Menéndez, Silvia; Sampayo Cordero, Miguel; Popa, Crina; Malfettone, Andrea; Cortés, Javier; Llombart Cussac, Antonio |
| 25-Sep-2019 | PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution | Pernas, Sònia; Petit, Anna; Climent, Fina; Paré, Laia; Perez Martin, J.; Ventura, Luz; Bergamino Sirvén, Milana; Galván, Patricia; Falo, Catalina; Morilla, Idoia; Fernandez Ortega, Adela; Stradella, Stradella; Rey, Montse; Garcia Tejedor, Amparo; Gil Gil, Miguel; Prat Aparicio, Aleix |
| 1-Dec-2017 | Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis | Martínez Aranda, Antonio; Hernández, Vanessa; Moreno, Ferran; Baixeras, Núria; Cuadras, Daniel; Urruticoechea Ribate, Ander; Gil Gil, Miguel; Vidal, Noemí; Andreu, Xavier; Seguí, Miquel A.; Ballester, Rosa; Castella, Eva; Sierra Jiménez, Àngels |
| 6-Sep-2012 | Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a restrospective cohort study in Catalonia, Spain. | Font, Rebeca; Espinàs Piñol, Josep Alfons; Gil Gil, Miguel; Barnadas i Molins, Agustí; Ojeda, B.; Tusquets, Ignasi; Seguí, Miquel A.; Margelí Vila, Mireia; Arcusa, Angels; Prat Marín, Andrés; García, M.; Borràs Andrés, Josep Maria |
| 8-May-2020 | Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study | Fernández de Larrea Baz, Nerea; Pérez Gómez, Beatriz; Guerrero Zotano, Angel; Casas, Ana Ma.; Bermejo de las Heras, Begoña; Baena Cañada, José Manuel; Antolin, Silvia; Sánchez Rovira, Pedro; Ramos Vázquez, Manuel; García Sáenz, José Ángel; Antón, Antonio; Muñoz Mateu, Montserrat; Juan, Ana de; Jara, Carlos; Chacón, José Ignacio; Arcusa, Angels; Gil Gil, Miguel; Adrover, Encarna; Oltra, Amparo; Brunet, Joan; González, Sonia; Bezares, Susana; Lope, Virginia; Martín, Miguel; Pollán, Marina |
| 1-Dec-2017 | Pseudoprogression as an adverse event of glioblastoma therapy | Balaña, Carmen; Capellades, Jaume; Pineda, Estela; Estival, Anna; Puig, Josep; Domènech, Sira; Verger, Eugènia; Pujol Farré, Teresa; Martínez García, Maria; Oleaga Zufiría, Laura; Velarde, Jose Maria; Mesia Barroso, Carlos; Fuentes, Rafael; Marruecos, Jordi; Barco, Sonia del; Villà, Salvador; Carrato, Cristina; Gallego, Oscar; Gil Gil, Miguel; Craven Bartle, Jordi; Alameda, Francesc; GLIOCAT Group |
| 31-Jul-2019 | Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients | Estival, Anna; Sanz, Carolina; Ramirez, Jose Luis; Velarde, Jose Maria; Domenech, Marta; Carrato, Cristina; Peñas, Ramón de las; Gil Gil, Miguel; Sepúlveda, Juan; Armengol, Roser; Cardiel, Isaac; Berrocal, Alfonso; Luque, Raquel; Herrero, Ana; Balana, Carmen |
| 21-Nov-2019 | Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center | Sirven, Milana Bergamino; Fernández Ortega, Adela; Stradella, Agostina; Morilla, Idoia; Falo, Catalina; Vázquez, Silvia; Castany, Roser; Villanueva, Rafael; Recalde, Sabela; Navarro Pérez, Valentí; Gil Gil, Miguel; Pernas, Sònia |